Who is sponsoring NCT05748847?

NCT05748847 is sponsored by Assiut University.

What drugs are being tested in NCT05748847?

Interventions in NCT05748847: Intrastromal corneal ring segment implantation (Pocket), Intrastromal corneal ring segment implantation (Tunnel).

What condition does NCT05748847 study?

NCT05748847 studies Keratoconus.

Is NCT05748847 still recruiting?

NCT05748847 is currently completed. Last updated 31 October 2024.

Last reviewed 2024-10-31 · How we verify

NCT05748847

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Pocket Versus Tunnel ICRS for Treatment of Keratoconus

Completed NA Last updated 31 October 2024

What this trial tests

NA trial testing Intrastromal corneal ring segment implantation (Pocket) in Keratoconus in 74 participants. Completed in 15 April 2023.

Timeline

1 June 2019

Primary endpoint
15 April 2023

15 April 2023

Quick facts

Lead sponsor	Assiut University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	74
Start date	1 June 2019
Primary completion	15 April 2023
Estimated completion	15 April 2023
Sites	1 location across Egypt

Drugs / interventions tested

Intrastromal corneal ring segment implantation (Pocket)
Intrastromal corneal ring segment implantation (Tunnel)

Conditions studied

Keratoconus — all drugs for Keratoconus →

Sponsor

Assiut University

Who can join

Adults 18 to 35, any sex, with Keratoconus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Keratoconus is a corneal degenerative disease associated with loss of best-corrected visual acuity. The use of intrastromal corneal ring segment implants is indicated to regularize the cornea and to reduce aberrations.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Complications and Outcomes of Femtosecond Laser-Assisted Corneal Pocket Implantation of 360-Degree MyoRing<sup>®</sup> Versus Corneal Tunnel Implantation of 340-Degree Keraring<sup>®</sup> for the Management of Central Keratoconus.
Abdel-Radi M, Anwar M, Mostafa MM. · · 2026 · PMID 41263332 · DOI 10.1080/02713683.2025.2587890

Verify or expand the search:

Other recruiting trials for Keratoconus

Currently open trials in the same condition.

NCT07372911 — PRoTECT: Corneal Wavefront Guided PRK + Epi-off CXL vs. PTK+Epi-off CXL in Keratoconus · NA · recruiting
NCT07461129 — Electrophysiological Changes in Cases of Different Stages of Keratoconus · active not recruiting
NCT06601101 — Effects of Topical Insulin on Corneal Epithelium Healing After Corneal Crosslinking in Patients With Keratoconus · Phase 3 · recruiting
NCT05516004 — Safety and Effectiveness of the PXL-Platinum 330 System for Cornea Crosslinking in Eyes With Cornea Thinning · Phase 2 · recruiting
NCT06798779 — Predicting Manifest Astigmatism in Keratoconus Patients. · active not recruiting

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05748847 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 31 October 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05748847.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing